A clinical-stage radiopharmaceutical company focused on developing targeted alpha-particle therapies for the treatment of cancer. Its pipeline centers on precision radiopharmaceuticals designed to deliver radioactive isotopes directly to tumors while limiting damage to surrounding tissue. Investors ...
No congressional trades have been disclosed for Perspective Therapeutics, Inc. (CATX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.